Mylan (NASDAQ:MYL) has been given a $41.00 target price by stock analysts at Cantor Fitzgerald in a research report issued on Tuesday. The brokerage presently has a “hold” rating on the stock. Cantor Fitzgerald’s price target indicates a potential downside of 3.00% from the company’s current price.
MYL has been the subject of several other reports. BidaskClub upgraded Mylan from a “buy” rating to a “strong-buy” rating in a research report on Tuesday, December 19th. BMO Capital Markets reiterated a “buy” rating and issued a $45.00 target price on shares of Mylan in a research report on Friday, September 29th. ValuEngine raised Mylan from a “hold” rating to a “buy” rating in a research note on Monday, October 2nd. Instinet reissued a “buy” rating and issued a $37.00 price target on shares of Mylan in a research note on Thursday, October 5th. Finally, Cowen reissued a “market perform” rating and issued a $36.00 price target (up previously from $30.00) on shares of Mylan in a research note on Thursday, October 5th. One analyst has rated the stock with a sell rating, seven have assigned a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the company. The stock has an average rating of “Buy” and a consensus target price of $42.78.
Mylan (NASDAQ MYL) opened at $42.27 on Tuesday. The firm has a market capitalization of $22,557.14, a P/E ratio of 26.25, a price-to-earnings-growth ratio of 3.13 and a beta of 1.38. Mylan has a 1 year low of $29.39 and a 1 year high of $45.87. The company has a debt-to-equity ratio of 1.05, a quick ratio of 0.95 and a current ratio of 1.46.
Several hedge funds and other institutional investors have recently added to or reduced their stakes in MYL. Bellwether Investment Group LLC grew its stake in shares of Mylan by 0.3% in the 2nd quarter. Bellwether Investment Group LLC now owns 6,622 shares of the company’s stock worth $257,000 after buying an additional 23 shares during the last quarter. Park National Corp OH lifted its holdings in shares of Mylan by 0.5% during the 2nd quarter. Park National Corp OH now owns 5,875 shares of the company’s stock valued at $254,000 after buying an additional 27 shares during the period. Rothschild Investment Corp IL lifted its holdings in shares of Mylan by 0.8% during the 3rd quarter. Rothschild Investment Corp IL now owns 5,542 shares of the company’s stock valued at $211,000 after buying an additional 42 shares during the period. E&G Advisors LP lifted its holdings in shares of Mylan by 0.4% during the 2nd quarter. E&G Advisors LP now owns 11,144 shares of the company’s stock valued at $482,000 after buying an additional 44 shares during the period. Finally, M Holdings Securities Inc. lifted its holdings in shares of Mylan by 0.9% during the 2nd quarter. M Holdings Securities Inc. now owns 6,254 shares of the company’s stock valued at $270,000 after buying an additional 55 shares during the period. 74.90% of the stock is owned by institutional investors.
COPYRIGHT VIOLATION WARNING: This piece was first published by American Banking and Market News and is the sole property of of American Banking and Market News. If you are reading this piece on another site, it was copied illegally and reposted in violation of international copyright law. The correct version of this piece can be viewed at https://www.americanbankingnews.com/2017/12/27/mylan-myl-given-a-41-00-price-target-by-cantor-fitzgerald-analysts.html.
Mylan Company Profile
Mylan N.V. is a global pharmaceutical company. The Company develops, licenses, manufactures, markets and distributes generic and branded generic products for resale by others; specialty pharmaceuticals, and active pharmaceutical ingredients (APIs). It operates through two segments: Generics and Specialty.
